Clinical Trial Update: Treatment of Hypoparathyroidism With Subcutaneous PTH (1-84) Injections: Effects on Muscle Function and Quality of Life [Phase 2]

View source ↗

Summary

This Phase 2 trial evaluates subcutaneous PTH (1-84) injections for hypoparathyroidism and reports on effects related to muscle function and quality of life.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypoparathyroidism

Drugs mentioned

• PTH(1-84) (parathyroid hormone 1-84)

Snippet

Sponsor: University of Aarhus | Conditions: Hypoparathyroidism | Phase 2 | Status: COMPLETED